Avita Medical (ASX:AVH) has appointed Cary Vance as chief executive, effective immediately, according to a Friday Australian bourse filing.
Vance has been acting as interim CEO since October 2025, per the filing.
The company also appointed Jan Stern Reed as chair with immediate effect, the filing added.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.